Recruiting Multiple Sclerosis Studies in Cullman
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or NRSPMS who were previou...
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of teriflunomide in male and female participants...
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
The primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab as measured by T1 Gadolinium (Gd)-enhancing lesions and pharmacokinetics in participants with ...
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. Th...
About Multiple Sclerosis Clinical Trials in Cullman
Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.
There are currently 4 multiple sclerosis clinical trials recruiting participants in Cullman, AL. These studies are seeking a combined 4,850 participants. Research is being sponsored by Sanofi, TG Therapeutics, Inc., Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Sclerosis Clinical Trials in Cullman — FAQ
Are there multiple sclerosis clinical trials in Cullman?
Yes, there are 4 multiple sclerosis clinical trials currently recruiting in Cullman, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cullman?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cullman research site will contact you about next steps.
Are clinical trials in Cullman free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cullman studies also compensate for your time and travel.
What multiple sclerosis treatments are being tested?
The 4 active trials in Cullman are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.
Data updated March 2, 2026 from ClinicalTrials.gov